查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1424409

製药 4.0 全球市场，按成分、按技术、按应用、按最终用户、按地区

Global Pharma 4.0 Market, By Component, By Technology, By Application, By End User, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 178 Pages | 商品交期: 2-3个工作天内

价格
简介目录

全球製药4.0市场规模预计将从2024年的167.5亿美元增至2031年的544.3亿美元，预测期内复合年增长率为18.3%。

报告范围 报告详情
基准年 2023年 2023/2024年市场规模 167.5亿美元
实际资料 2019年至2023年 预测期 2024-2031
预测期2023/2024~2030/2031年复合成长率： 18.30% 2030/2031价值预测 544.3亿美元
图 1. 2024 年按地区分類的製药 4.0全球市场占有率(%)
全球製药4.0市场-IMG1

「製药4.0」指依照工业4.0原则对製药业进行转型。工业4.0的特点是将物联网（IoT）、人工智慧（AI）、巨量资料分析、云端运算和网实整合系统等先进技术整合到製造过程中。在製药业中，这转化为药物开发、製造、供应链管理和整体业务效率的改善。製药4.0是指製药业的第四次工业革命，其特点是物联网（IoT）、巨量资料分析、人工智慧（AI）和机器学习等先进技术的融合。这些技术正在彻底改变医药价值链的许多方面，从研发到临床试验和生产。我们也透过帮助製药公司开发创新的标靶治疗和精准医疗来实现个人化医疗保健。随着领先公司越来越多地采用这些新兴技术来最大限度地降低成本、提高生产力并获得竞争优势，全球製药 4.0 市场预计将在未来几年显着成长。

市场动态：

全球製药 4.0 市场的推动因素包括改进药物研发和市场开拓流程的需求不断增长、对个性化药物的需求不断增加、对製造业务数位化的日益关注以及製药公司旨在提高供应链可视性和效率。几个因素，包括企业目标。然而，引入新技术所需的高投资成本以及安全漏洞和网路攻击的风险为市场成长带来了挑战。 Pharma 4.0 透过实现资料驱动的研发、临床试验和供应链中断的预测分析、新数位疗法的开发以及采用 3D 列印进行定製药物製造，提供了巨大的机会。主要企业正在专注于新产品的发布和合作伙伴关係，以利用这些机会。

本研究的主要特点

  • 本报告对全球製药4.0市场进行了详细分析，并提供了以2023年为基准年的预测期（2024-2031）的市场规模和年复合成长率（CAGR%）。
  • 它还揭示了各个细分市场的潜在商机，并为该市场说明了一系列有吸引力的投资提案。
  • 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要考察。
  • 它根据公司亮点、产品系列、主要亮点、财务表现和策略等参数，介绍了全球製药 4.0 市场的主要企业。
  • 该报告的见解使行销人员和公司负责人能够就未来的产品发布、升级、市场扩张和行销策略做出明智的决策。
  • 全球製药 4.0 市场报告针对该行业的各个相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
  • 透过用于分析全球製药 4.0 市场的各种策略矩阵，促进相关人员的决策。

目录

第一章 研究目的与前提

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告说明
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map（COM）

第三章市场动态、法规及趋势分析

  • 市场动态
    • 增加产品发布
    • 资料安全和隐私问题
    • 人工智慧和分析的进步
  • 主要亮点
  • 监管场景
  • 市场趋势
  • PEST分析
  • 波特的分析
  • 产品发表会
  • 技术进步
  • 合併、收购和合作

第四章全球製药 4.0 市场 -冠状病毒(COVID-19) 大流行的影响

  • 新型冠状病毒感染疾病（COVID-19）的流行病学
  • 供需面分析
  • 经济影响

第五章 全球製药 4.0 市场（按组成部分），2019-2031 年

  • 硬体
  • 软体
  • 服务

第六章 全球製药 4.0 市场（依技术），2019-2031

  • 云端运算,
  • 人工智慧
  • 巨量资料分析
  • 物联网

第七章 全球製药 4.0 市场（依应用），2019-2031

  • 研究与开发
  • 製造业
  • 供应链管理
  • 其他的

第 8 章 全球製药 4.0 市场，依最终用户划分，2019-2031 年

  • 生物製药公司
  • 契约製造组织
  • 合约研究组织

第9章全球製药4.0市场，依地区，2019-2031

  • 北美洲
  • 美国
  • 加拿大
  • 欧洲
  • 德国
  • 英国
  • 西班牙
  • 法国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • ASEAN
  • 其他亚太地区
  • 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 海湾合作委员会国家
  • 以色列
  • 其他中东地区
  • 非洲
  • 北非
  • 中部非洲
  • 南非

第10章竞争形势

  • 公司简介
    • Oracle
    • GE Healthcare
    • Optum, Inc.
    • Honeywell International Inc.
    • IBM Corporation
    • Cisco Systems, Inc
    • Siemens Healthcare GmbH
    • POLARISqb
    • Google Cloud
    • Optibrium
    • Syntekabio
    • Fujitsu Limited
    • SAS Health
    • Microsoft
    • Lotte Healthcare

第11章 章节

  • 参考
  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI6542

The global pharma 4.0 market size is expected to reach US$ 54.43 Bn by 2031 from US$ 16.75 Bn in 2024, exhibiting a compound annual growth rate (CAGR) of 18.3% during the forecast period.

Report Coverage Report Details
Base Year: 2023 Market Size in 2023/2024: US$ 16.75 Bn
Historical Data for: 2019 to 2023 Forecast Period: 2024-2031
Forecast Period 2023/2024 to 2030/2031 CAGR: 18.30% 2030/2031 Value Projection: US$ 54.43 Bn
Figure 1. Global Pharma 4.0 Market Share (%), By Region, 2024
Global Pharma 4.0 Market - IMG1

The term "Pharma 4.0" refers to the transformation in the pharmaceutical industry that is aligned with the principles of Industry 4.0. Industry 4.0 is characterized by the integration of advanced technologies such as the Internet of Things (IoT), artificial intelligence (AI), big data analytics, cloud computing, and cyber-physical systems into manufacturing processes. In the context of the pharmaceutical industry, this translates to improvements in drug development, manufacturing, supply chain management, and overall operational efficiency. Pharma 4.0 refers to the fourth industrial revolution in the pharmaceutical industry, characterized by the integration of advanced technologies like the Internet of Things (IoT), big data analytics, artificial intelligence (AI), and machine learning. These technologies are revolutionizing various aspects of the pharmaceutical value chain from research and development, clinical trials, production. They are also enabling personalized healthcare by helping pharma companies develop innovative targeted therapies and precision medicine. The global pharma 4.0 market is projected to grow significantly in the coming years as major players are increasingly adopting these emerging technologies to minimize costs, enhance productivity, and gain a competitive edge.

Market Dynamics:

The global pharma 4.0 market is driven by several factors, such as the growing need to improve drug discovery and development processes, rising demand for personalized medicines, an increasing focus on digitalizing manufacturing operations, and the aims of pharmaceutical companies to enhance supply chain visibility and efficiency. However, the high investment costs required for the implementation of emerging technologies, the risks of security breaches, and cyberattacks pose challenges to market growth. Pharma 4.0 offers huge opportunities by enabling data-driven research and development, predictive analytics for clinical trials and supply chain disruptions, the development of new digital therapies, and the adoption of 3D printing for customized drug manufacturing. Key players are focusing on new product launches and partnerships to capitalize on these opportunities.

Key features of the study:

  • This report provides in-depth analysis of the global pharma 4.0 market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period (2024-2031), considering 2023 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global pharma 4.0 market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study Oracle,GE Healthcare, Optum, Inc., Honeywell International Inc., IBM Corporation, Cisco Systems, Inc., Siemens Healthcare GmbH, POLARISqb, Google Cloud, Optibrium, Syntekabio, Fujitsu Limited, SAS Health, Microsoft and Lotte Healthcare
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global pharma 4.0 market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pharma 4.0 market

Detailed Segmentation:

  • Global Pharma 4.0 Market, By Component
    • Hardware
    • Software
    • Services
  • Global Pharma 4.0 Market, By Technology
    • Cloud Computing
    • Artificial Intelligence
    • Big Data Analytics
    • Internet of Things
  • Global Pharma 4.0 Market, By Application
    • Research and Development
    • Manufacturing
    • Supply Chain Management
    • Others
  • Global Pharma 4.0 Market, By End User
    • Biopharmaceutical Companies
    • Contract Manufacturing Organizations
    • Contract Research Organizations
  • Global Pharma 4.0 Market, By Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Top Companies in the Global Pharma 4.0 Market:
    • Oracle
    • GE Healthcare
    • Optum, Inc.
    • Honeywell International Inc.
    • IBM Corporation
    • Cisco Systems, Inc.
    • Siemens Healthcare GmbH
    • POLARISqb
    • Google Cloud
    • Optibrium
    • Syntekabio
    • Fujitsu Limited
    • SAS Health
    • Microsoft
    • Lotte Healthcare

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Component
    • Market Snippet, By Technology
    • Market Snippet, By Application
    • Market Snippet, By End User
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Increasing Product Launch
    • Data Security and Privacy Concerns
    • Advancements in Artificial Intelligence and Analytics
  • Key Highlights
  • Regulatory Scenario
  • Market Trends
  • PEST Analysis
  • PORTER's Analysis
  • Product Launches
  • Technological Advancements
  • Mergers, Acquisitions, and Collaborations

4. Global Pharma 4.0 Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Pharma 4.0 Market, By Component, 2019-2031, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Hardware
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Software
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Services
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)

6. Global Pharma 4.0 Market, By Technology, 2019-2031, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Cloud Computing,
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Artificial Intelligence
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Big Data Analytics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Internet of Things
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)

7. Global Pharma 4.0 Market, By Application, 2019-2031, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Research and Development
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Manufacturing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Supply Chain Management
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)

8. Global Pharma 4.0 Market, By End User, 2019-2031, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Biopharmaceutical Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Contract Manufacturing Organizations
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Contract Research Organizations
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)

9. Global Pharma 4.0 Market, By Region, 2019-2031, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Region, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, For Region, 2020 -2031
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Component, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Component, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Component, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Component, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Component, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Component, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019-2031,(US$ Bn)
  • North Africa
  • Central Africa
  • South Africa

10. Competitive Landscape

  • Company Profile
    • Oracle
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • GE Healthcare
    • Optum, Inc.
    • Honeywell International Inc.
    • IBM Corporation
    • Cisco Systems, Inc
    • Siemens Healthcare GmbH
    • POLARISqb
    • Google Cloud
    • Optibrium
    • Syntekabio
    • Fujitsu Limited
    • SAS Health
    • Microsoft
    • Lotte Healthcare
  • Analyst Views

11. Section

  • References
  • Research Methodology
  • About us